Alpha-mangostin suppresses the production of inflammatory cytokine in P.
INTRODUCTION
Porphyromonas gingivalis is involved in the pathogenesis of periodontitis, a chronic inflammatory disease that destroys the tissues supporting the tooth (1) . The LPS of P.
gingivalis is a virulence factor that plays a crucial role in mediating inflammation and stimulating production of pro-inflammatory cytokines by immune cells (2) . Monocytes are part of the innate immunity which constitutes the first line of defense against periodontal pathogens. These cells are involved in the development of periodontal inflammation and destruction (3, 4) . Previous studies have shown that P. gingivalis LPS stimulates monocytes to exhibit increased production of proinflammatory cytokines such as IL-1β and IL-8 (5, 6).
IL-1β and IL-8 plays a significant role in the pathogenesis of periodontal disease.
Previous studies have confirmed that the IL-1β levels in both gingival crevicular fluid (GCF) and periodontal tissue of periodontitis patients are increased in relation to the severity of inflammation (7, 8) and IL-1β level in GCF is reduced following periodontal treatment (9) .
The chemotactic effects of IL-8 in inflamed gingiva may contribute to the resorption of alveolar bone (10, 11) . The level of IL-8 is greatly increased in inflamed periodontal tissue and periodontal therapy reduced the expression of this cytokine (12) , thus level of IL-8 is associated with periodontal status.
Alpha-mangostin, the dominant xanthone found in the pericarps of mangosteen, possesses anti-inflammatory activities by decreasing expression of pro-inflammatory mediators and activation of signaling pathways. These effects include the finding that alphamangostin decreased LPS-stimulated IL-1β, tumor necrosis factor (TNF)-α, IL-4, and IL-8 expression in human adipocytes (13) and U937 cells (14) . Treatment of E coli LPS-stimulated U937 cells with alpha-mangostin has shown to decrease MAPK activation (14, 15) . In human monocytic cell line THP-1, the inhibitory effect of alpha-mangostin has been report only in Escherichia coli LPS-stimulated TNF-α and IL-8 production (16) . However, the efficacy of alpha-mangostin on IL-1β and IL-8 expression and activation of MAPK signaling in P.
gingivalis LPS stimulated human monocytes has not been elucidated. Therefore, the purpose of this study was to investigate the inhibitory effects of alpha-mangostin on the P. gingivalis LPS-induced IL-1β and IL-8 production and the MAPK activation in THP-1 cells.
SUBJECTS AND METHODS

Preparation of alpha-mangostin
Alpha-mangostin was isolated and purified as previously described (17) . The yield of alphamangostin from the dried pericarp was approximately 0.4% (w/w). The stock solution of alpha-mangostin was dissolved in dimethysulfoxide (DMSO) and sterilized by filtration through 0.2 m disc filters.
Cell culture
This study was approved by the Naresuan University Institutional Review Board (COE No. 057/2015). THP-1 cells were obtained from the European Collection of Cell Cultures. Cells were maintained in RPMI 1640 (Hyclone, Cramlington, UK) containing 10% heat-inactivate fetal bovine serum (Hyclone), L-glutamine (2 mM), penicillin (100 U/mL), and streptomycin (100 μg/mL) in 5% CO2 at 37 °C.
Cytotoxicity assays
The effect of alpha-mangostin and P. gingivalis LPS on the viability of THP- formazan absorbance was recorded using a microplate reader (Bio-Rad Laboratories, CA, USA) at 490 nm. These experiments were repeated three independent times in triplicate wells.
P. gingivalis LPS challenge
THP-1 cells were seeded in a 6-well plate at a density of 3x10 5 cells per well and incubated in absence (controls) or presence of 0.5, 0.75, and 1.0 μg/ml of P. gingivalis LPS. RT-PCR and ELISA were performed.
RT-PCR analysis of IL-1β and IL-8 mRNA levels
THP-1 cells were seeded in a 6-well plate at a density of 3x10 5 cells per well. Data were analyzed with the LightCycler® 480 software. Quantification was calculated using the starting quantity of the cDNA of interest relative to that of GAPDH cDNA in the same sample.
ELISAs for IL-1β and IL-8 determination
The culture supernatants obtained from real-time PCR experiments were collected to quantify cytokine production. Value of IL-1β and IL-8 were measured by sandwich ELISA kit (Biolegend, CA, USA) according to the manufacturer's instructions. All measurements were performed in duplicate and were repeated at three different occasions.
Western blotting analysis
THP1 cells were pretreated with 0.5 μg/ml P. gingivalis LPS for 30 min and treated with 0.25, 0.5, and 1.0 μg/ml alpha-mangostin for 3 h. Then, cells were washed with PBS and the whole cells were extracted with protease and phosphatase inhibitors. Mixed proteins were determined the concentration using a bicinchoninic acid kit (Pierce Biotechnology, IL, USA).
The volume of extracted protein was determined to 80 µg in each well of 10% SDS polycrylamide gel and transferred to polyvinylidene difluoride membranes. The activations of JNK, ERK1/2 and p38 MAPK were assessed using anti-phospho-ERK1/2 antibody (Upstate Biotechnology, NY, USA), anti-phospho-JNK, and anti-phospho-p38 MAPK antibodies (Cell Signaling Technology, MA, USA). Immunoreactive proteins were observed under under CCD camera (GE Healthcare Life Sciences, PA, USA).
Statistical analysis
Statistical analyses were performed using the SPSS 17.0 software. All data were expressed as mean ± standard deviation (SD). Differences between experimental groups were analyzed ANOVA followed by Tukey HSD comparison test. The level of statistical significance was set at p < 0.05.
RESULTS
Cytotoxic effect of P. gingivalis LPS and alpha-mangostin on THP-1 cells
The in vitro cytotoxicity was analyzed by MTS assay and was expressed as a percentage of control values. P. gingivalis LPS (Fig. 1A) and alpha-mangostin (Fig. 1B) showed no cytotoxic effect at the concentrations up to 1 μg/ml (p < 0.05). for 24 h. The MTS assay was used to measure cell viability. The data (mean ± SD) are the average of three independent experiments performed in triplicate.
Effects of P. gingivalis LPS on the mRNA and protein expression level of IL-1β and IL-8 in THP-1 cells
The mRNA expression levels of IL-1β and IL-8 were increased significantly when THP-1 cells were treated with P. gingivalis LPS 0.5, 0.75, and 1.0 μg/ml ( Fig. 2A and 2B ). These results were consistent with the IL-1β and IL-8 protein expression (Fig. 2C and 2D ). These dose-dependent experiments suggest that the expression of IL-1β and IL-8 in THP-1 cells were modulated by P. gingivalis LPS. In the following experiment, P. gingivalis LPS at concentration of 0.5 μg/ml was applied in all experiments. 
Effects of alpha-mangostin on IL-1β and IL-8 mRNA expression in P. gingivalis LPSstimulated THP-1 cells
To investigate the suppression effect of alpha-mangostin, THP-1 cells were pre-treated with P. gingivalis LPS, and subsequently treated with 0.25, 0.5, and 1.0 μg/ml alpha-mangostin.
Alpha-mangostin 0.5 and 1.0 μg/ml significantly reduced the mRNA expression of P.
gingivalis LPS-upregulated IL-1β (Fig. 3A) and IL-8 ( Fig. 3B) (p < 0.05). gingivalis LPS stimulated THP-1 cells. Cells were incubated with 0.5 μg/ml of P. gingivalis LPS for 3 h, followed by alpha-mangostin treatment for 16 h. Cells were extracted for RT-PCR and levels of IL-1β and IL-8 were normalized to GAPDH. Histograms represent mean ± SD of relative quantification from three independent experiments. *indicates p < 0.05, when compared with P. gingivalis LPS-stimulated untreated cells.
Effects of alpha-mangostin on IL-1β and IL-8 protein expression in P. gingivalis LPSstimulated THP-1 cells
In order to confirm the suppression effect of alpha-mangostin, the ELISA was used to detect IL-1β and IL-8 protein expression. Similar to previous experiment, treatment with 0.5 and 1 μg/ml alpha-mangostin significantly inhibited P .gingivalis LPS-upregulated IL-1β and IL-8 protein expression (p < 0.05) (Fig. 4) . Again, alpha-mangostin suppressed P. gingivalis LPSinduced increases in the expression of IL-8 protein in a dose-dependent manner. 
Effect of alpha-mangostin on P. gingivalis LPS-mediated MAPK activation
MAPK is considered to be the central pathway for the regulation of inflammatory cytokine production, expression of three MAPK signaling molecules were examined using immunoblotting. P. gingivalis LPS treatment induced the phosphorylation of JNK, ERK1/2 and p38 MAPK, and 0.5 and 1.0 μg/ml alpha-mangostin treatment decreased these responses in a dose-dependent manner (Fig. 5) . The lowest protein levels of JNK, ERK1/2 and p38 MAPK phosphorylation were reduced to 63.06%, 61.83% and 46.39%, respectively, compared with that in the P. gingivalis LPS-treated cells. These data demonstrate that alphamangostin could inhibit the activation of MAPK signaling in P. gingivalis LPS stimulated-THP-1 cells. Coli LPS-stimulated human adipocytes and U937 cells can be partly attributed to preventing the activation of MAPK signaling pathways (14, 15) . P. gingivalis LPS directly induced activation of MAPK signaling pathways that is especially relevant for expression of inflammatory genes during periodontal disease progression (19) . In human monocytes, P.
gingivalis LPS was reported to induce JNK ( 
CONCLUSIONS
These results demonstrate that alpha-mangostin inhibited IL-1β and IL-8 production upon stimulation with P. gingivalis LPS in THP-1 cells. These effects were mediated by reducing MAPK activation. This suggests that alpha-mangostin, by reducing inflammatory response in THP-1 cells, may be beneficial in the treatment of periodontal disease.
